First Time Loading...
J

Jiangxi Fushine Pharmaceutical Co Ltd
SZSE:300497

Watchlist Manager
Jiangxi Fushine Pharmaceutical Co Ltd
SZSE:300497
Watchlist
Price: 10.04 CNY -2.14%
Updated: Jun 17, 2024
Have any thoughts about
Jiangxi Fushine Pharmaceutical Co Ltd?
Write Note

Gross Margin
Jiangxi Fushine Pharmaceutical Co Ltd

10.5%
Current
21%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
10.5%
=
Gross Profit
162.7m
/
Revenue
1.6B

Gross Margin Across Competitors

Country CN
Market Cap 5.4B CNY
Gross Margin
10%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 834.9B USD
Gross Margin
80%
Country DK
Market Cap 4.4T DKK
Gross Margin
85%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country US
Market Cap 350.3B USD
Gross Margin
70%
Country US
Market Cap 327.9B USD
Gross Margin
75%
Country UK
Market Cap 193.9B GBP
Gross Margin
82%
Country CH
Market Cap 197.4B CHF
Gross Margin
73%
Country CH
Market Cap 185.9B CHF
Gross Margin
74%
Country US
Market Cap 156B USD
Gross Margin
70%

Profitability Report

View the profitability report to see the full profitability analysis for Jiangxi Fushine Pharmaceutical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
10.5%
=
Gross Profit
162.7m
/
Revenue
1.6B
What is the Gross Margin of Jiangxi Fushine Pharmaceutical Co Ltd?

Based on Jiangxi Fushine Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 10.5%.